comparemela.com

Ridge Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Annual Financial Report for the Year Ended 31 March 2023

15 June 2023 NORTHERN 3 VCT PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2023 Northern 3 VCT PLC is a Venture Capital Trust managed by Mercia Fund Management Limited. It invests. | June 15, 2023

Annual Financial Report for the Period Ended 31 March 2023

15 JUNE 2023 NORTHERN VENTURE TRUST PLC ANNUAL FINANCIAL REPORT FOR THE PERIOD ENDED 31 MARCH 2023 Northern Venture Trust PLC is a Venture Capital Trust whose investment adviser is. | June 15, 2023

Investegate |Northern Venture Tst Announcements | Northern Venture Tst: Annual Financial Report

RDIF and TopRidge Pharma agree to produce over 100 million doses of the Sputnik V vaccine in China

Search jobs 01-Apr-2021 RDIF and TopRidge Pharma agree to produce over 100 million doses of the Sputnik V vaccine in China RDIF and Moscow, April 1, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and TopRidge Pharma (a subsidiary company of one of China’s pharmaceutical market leaders, Tibet Rhodiola Pharmaceutical Holding), have agreed to cooperate on production of over 100 million doses per year of the world’s first registered vaccine against coronavirus Sputnik V in China. This amount of the vaccine will be sufficient to vaccinate over 50 million people. The parties also intend to cooperate on clinical trials of the vaccine in China and promotion of Sputnik V in the country. TopRidge Pharma will be able to distribute the vaccine in mainland China as well as in Hong Kong, Macao and Taiwan subject to all appropriate regulatory approvals.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.